An updated systematic review evaluating the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and ...

By Nancy Lapid Aug 31 (Reuters) - People taking popular GLP-1 obesity drugs who remain on low starter doses will lose some weight but may still experience side effects, although significantly less ...

When Brazilian customs agents opened jars of dulce de leche aboard a tourist bus arriving from Paraguay in April, they discovered hundreds of vials of tirzepatide, the active ingredient in the popular ...

President Trump vowed better access to GLP-1 weight loss drugs for Medicaid recipients. But thus far only Indiana has publicly signed on with the administration’s demo.

Body mass index, or BMI, has been used for decades to assess healthy weight. But a Penn State Health obesity medicine ...

While our appetite-control system is quite complex, there are easy ways to help you feel fuller for longer for better ...

In the majority of states that don’t cover GLP-1s, Medicaid enrollees can pay out-of-pocket through the president’s drug-discount platform, TrumpRx. But the discounted prices — around $350 a month on ...

Some of the platforms in the ranking below may offer medications (like Ozempic) that are not approved by the U.S. Food and ...

In the two-year DELISH randomized trial, adults with obesity achieved modest, sustained weight loss with either an adapted ...

The great majority of people taking part in a study lost weight by following personalised nutritional insights, rather than ...

New research shows that a keto diet may offer more metabolic benefits than either a Mediterranean or low fat, plant-forward diet in people with obesity.

A low-fat vegan diet may help people lose weight without counting calories, shrinking portions, or feeling constantly hungry. In a 16-week clinical trial, people eating mostly fruits, vegetables, ...